Combination Immunotherapy with Cytotoxic T-Lymphocyte–Associated Antigen-4 and Programmed Death Protein-1 Inhibitors Prevents Postoperative Breast Tumor Recurrence and Metastasis

Ting Sun(Shanghai Ninth People's Hospital), Huadan Xue(Chinese Academy of Medical Sciences & Peking Union Medical College), Zhengyu Jin(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuan Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Yang Du(Chinese Academy of Sciences), Wenjia Zhang(Yunnan University), Jie Tian(Shandong Institute of Automation)
Molecular Cancer Therapeutics
December 3, 2019
Cited by 25


Related Papers